Diabetes

Diabetes drug liraglutide may cause insulin-producing beta cells to deteriorate.

Erectile dysfunction drugs may improve insulin sensitivity and secretion in patients with prediabetes.

The FDA has accepted for review Sanofi's new drug application for its fixed-ratio combination of basal insulin glargine 100 units/mL and lixisenatide for the treatment of type 2 diabetes.

Diabetes and other conditions are also influenced by a person’s height.

Diabetes is a complex autoimmune condition that requires many treatment and education strategies to achieve health goals beyond glycemic control.

Type 1 diabetes is an autoimmune disease in which the beta cells of the pancreas are destroyed and are unable to produce an adequate amount of the hormone insulin.

The FDA has approved Tresiba (insulin degludec injection) to improve glycemic control in adults with diabetes mellitus.

Encapsulated human islet cells could improve maintenance of blood sugar levels in patients with diabetes.

Poor medication adherence is responsible for unnecessary illness, hospitalizations, disability, and premature death, particularly among patients with chronic diseases.

Diabetes is not a fun condition.

Medication adherence outreach should target patients who have multiple out-of-network claims.

Predictors of poor medication adherence include increased regimen complexity, multiple comorbidities, and high medication cost.

Supplementing insulin therapy combined with other glucose lowering agents may improve outcomes for T1DM patient.

Supplementing insulin therapy combined with other glucose lowering agents may improve outcomes for T1DM patient.

More than 20,000 articles have been written on how poor medication adherence, which costs the United States between $68 to $146 billion annually, increases adverse clinical outcomes and mortality.

Once-daily, long-acting basal insulin was approved in September 2015 for improving glycemic control in adults with diabetes.

Once-daily, long-acting basal insulin was approved in September 2015 for improving glycemic control in adults with diabetes.

Novo Nordisk's insulin degludec injection is now available in pharmacies nationwide.

Some studies have reported an association between marijuana use and individual metabolic syndrome factors, while others have found no relationship.

Prescription-only technology with insurance reimbursement helps patients and prescribers better manage diabetes.

The FDA today approved Eli Lilly's Humulin R U-500 insulin human injection (KwikPen) for patients with type 1 and type 2 diabetes who need more than 200 units of insulin per day.

Metformin decreased inflammation and scarring observed in more common pancreatic cancers.

Diabetes associated with a 60% increased risk of dementia for both men and women.

Diabetes associated with a 60% increased risk of dementia for both men and women.

Because diabetes is among the most common conditions for which pharmacies will dispense medications, a number of pharmacy technicians seek to better understand the disease.